132 related articles for article (PubMed ID: 37586214)
1. TFAP2A activates HMGA1 to promote glycolysis and lung adenocarcinoma progression.
Zhao J; Lan G
Pathol Res Pract; 2023 Sep; 249():154759. PubMed ID: 37586214
[TBL] [Abstract][Full Text] [Related]
2. TFAP2A upregulates SKA3 to promote glycolysis and reduce the sensitivity of lung adenocarcinoma cells to cisplatin.
Liu G; Liu X; Zeng W; Zhou W
Pharmacology; 2024 Apr; ():. PubMed ID: 38643755
[TBL] [Abstract][Full Text] [Related]
3. HMGA1 is a Prognostic Biomarker and Correlated with Glycolysis in Lung Adenocarcinoma.
Ma Y; Ma X; Du B; Li X; Li Y
J Cancer; 2024; 15(10):2913-2927. PubMed ID: 38706894
[No Abstract] [Full Text] [Related]
4. The E2F1/MELTF axis fosters the progression of lung adenocarcinoma by regulating the Notch signaling pathway.
Zhang L; Shi L
Mutat Res; 2023; 827():111837. PubMed ID: 37820570
[TBL] [Abstract][Full Text] [Related]
5. GRP75-mediated upregulation of HMGA1 stimulates stage I lung adenocarcinoma progression by activating JNK/c-JUN signaling.
Qiao GB; Wang RT; Wang SN; Tao SL; Tan QY; Jin H
Thorac Cancer; 2021 May; 12(10):1558-1569. PubMed ID: 33755320
[TBL] [Abstract][Full Text] [Related]
6. TFAP2A-induced SLC2A1-AS1 promotes cancer cell proliferation.
Cui Y; Zhang C; Ma S; Guan F
Biol Chem; 2021 May; 402(6):717-727. PubMed ID: 33580997
[TBL] [Abstract][Full Text] [Related]
7. TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway.
Xiong Y; Feng Y; Zhao J; Lei J; Qiao T; Zhou Y; Lu Q; Jiang T; Jia L; Han Y
Cell Death Dis; 2021 Apr; 12(4):352. PubMed ID: 33824285
[TBL] [Abstract][Full Text] [Related]
8. Transcription Factor FOXA1 Facilitates Glycolysis and Proliferation of Lung Adenocarcinoma via Activation of TEX19.
Zhang Y; Sheng H; Fu Y; Chen L
Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37606876
[TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis.
Chen W; Li X; Du B; Cui Y; Ma Y; Li Y
Cancer Med; 2023 Feb; 12(4):4421-4433. PubMed ID: 35924724
[TBL] [Abstract][Full Text] [Related]
10. NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis.
Zhang Z; Qi D; Liu X; Kang P
Clin Respir J; 2023 Sep; 17(9):884-892. PubMed ID: 37553792
[TBL] [Abstract][Full Text] [Related]
11. FOXA1/UBE2T Inhibits CD8
Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
Hu Y; Mu H; Deng Z
Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
[TBL] [Abstract][Full Text] [Related]
13. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
14. TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma.
Guoren Z; Zhaohui F; Wei Z; Mei W; Yuan W; Lin S; Xiaoyue X; Xiaomei Z; Bo S
Int J Biol Sci; 2020; 16(3):504-514. PubMed ID: 32015686
[TBL] [Abstract][Full Text] [Related]
15. LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p/HMMR axis.
Li Z; Zhu T; Yao F; Shen X; Xu M; Fu L; Wu Y; Ding J; Zhang J; Zhao J; Dong L; Wang X; Yu G
J Bioenerg Biomembr; 2024 Apr; 56(2):181-191. PubMed ID: 38411863
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
17. Transcription Factor MITF Inhibits the Transcription of CPT1B to Regulate Fatty Acid β-Oxidation and Thus Affects Stemness in Lung Adenocarcinoma Cells.
Tang W; Tang H; Xu S; Yu H; Chen Z
Pharmacology; 2024; 109(1):52-64. PubMed ID: 38016436
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
Xu Y; Lin L; Lv D; Yan S; He S; Ge H
Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
[TBL] [Abstract][Full Text] [Related]
20. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]